LICHEN SIMPLEX CHRONICUS

Clinical trials for LICHEN SIMPLEX CHRONICUS explained in plain language.

Never miss a new study

Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear

Sign up with your email to follow new studies for LICHEN SIMPLEX CHRONICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for relentless itch: phase 3 drug trial targets lichen simplex chronicus

Symptom relief Ongoing

This study tests if dupilumab injections can reduce severe itching in adults with lichen simplex chronicus, a condition causing thick, itchy skin patches. About 142 participants will receive either dupilumab or a placebo for 24 weeks. The main goal is to see if more people get me…

Matched conditions: LICHEN SIMPLEX CHRONICUS

Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief

Last updated May 17, 2026 03:58 UTC

LICHEN SIMPLEX CHRONICUS

Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear

New hope for relentless itch: phase 3 drug trial targets lichen simplex chronicus